Companion Animal – Antibiotics

ORBAX® Tablets

Product Description

ORBAX® (Orbifloxacin) Tablets are for the management of diseases in dogs associated with bacteria that is susceptible to orbifloxacin.

Product NamePkg SizeGTIN#/UPC#UIN#
ORBAX® Tablets22.7 mg x 250300611141018058809
ORBAX® Tablets68 mg x 100300611174016058811


ORBAX® Tablets (orbifloxacin) 22.7mg & 68mg


No items to show.



No items to show.


Important Safety Information:
Quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. Orbifloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. In animals with known or suspected central nervous system (CNS) disorders. In such animals, quinolones have, in rare instances, been associated with CNS stimulation, which may lead to convulsive seizures. The use of fluoroquinolones in cats has been reported to adversely affect the retina and should be used with caution in cats. Blindness has also been reported post-approval in cats. In some cases, blindness has been temporary. See Package Insert for full information including side effects, precautions, warnings and contraindications.